Page 90 - Buku Referensi Biopolimer Kitosan

Savjani, K.T, Gajjar, A.K, and Savjani, J.K. 2012. Drug Solubility:
Importance and Enhancement Techniques.

Schultheiss, N., and Henck, J.A. 2012. Role of Co-crystals in the
Pharmaceutical Development Continuum. In:Wouters,
J., Quere, L (Eds). Pharmaceutical Salts and Co-crystals.
Cambridge : The Royal Society of Chemistry, pp :110-27.

Sekiguchi, K. and Obi, N. 1961. Studies on absorption of
eutecticmixtures. I.A. comparison of the behaviour of
eutectic mix-tures of sulphathiazole and that of ordinary
sulphathiazole inman. Chemical and Pharmaceutical
Bulletin. 9, 866–872.

Sinko, P.J. 2016. Martin’s Physical Pharmacy And Pharmaceutical
Sciences. New Jersey, Wolters Kluwer.

Storck, S., Bretinger, H., and Maier, W.F. 1998. Characterization of
micro- and mesoporous solids by physisorption methods and
pore-size analysis, Applied Catalysis A: General, 174: 137–146.
Streit, F., Koch F, Laranjeira MCM, and Ninow JL. 2009. Production of
fungal chitosan in liquid cultivation using apple pomace as

substrate. Braz J Microbiol. 40: 20–25.
Sunkara, G. and Kompella, U.B. 2002. Drug delivery applications
of supercritical luid technology. Drug Delivery

Teckeshavhnology. 2, 44–50.
Synowiecki, J. 1986. Use of krill chitin as an enzyme support. In R. A.
A. Muzzarelli, C. Jeuniaux, G. Gooday Eds., Chitin in Nature
and Technology, New York: Plenum Press. 417-420.

Synowiecki, J, and Al-Khateeb NA. 2003. Production, Properties, and
some New Applications of Chitin and Its Derivatives. Critical
Review in Food Science and Nutrition. 43(2): 145-171.

82 BIOPOLIMER KITOSAN DAN PENGGUNAANNYA ALAM FORMULASI OBAT